The role of cytokines in the failing human heart

Cardiology Clinics

Volumn 16, Issue 4, 1998, Pages 645-656

  Kapadia, S ^a   Dibbs, Z ^a   Kurrelmeyer, K ^a   Kalra, D ^a   Seta, Y ^a   Wang, F ^a   Bozkurt, B ^a   Oral, H ^a   Sivasubramanian, N ^a   Mann, D L ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; CAT; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; HEART HEMODYNAMICS; HEART VENTRICLE PRESSURE; HUMAN; INFLAMMATION; LUNG EDEMA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STRESS;

EID: 0031793058     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8651(05)70041-2     Document Type: Article

References (85)

1. D. Aderka H. Engelmann Y. Maor Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors J Exp Med 175 1992 323 329
2. J. Anderson J.F. Carlquist E.H. Hammond Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy Lancet 2 1982 1124 1127
3. S.D. Anker T.P. Chua P. Ponikowski Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia Circulation 96 1997 526 534
4. S.D. Anker K.R. Egerer H.D. Volk Elevated soluble CD14 receptors and altered cytokines in chronic heart failure Am J Cardiol 79 1997 1426 1429
5. S.D. Anker J.W. Swan C. Felton TNF-α as predictor of peak leg blood flow in chronic heart failure [abstr] Circulation 92 1995 I-430
6. A.A. Ansari Y.C. Wang D.J. Danner Abnormal expression of histocompatibility and mitochondrial antigens by cardiac tissue from patients with myocarditis and dilated cardiomyopathy Am J Pathol 139 1991 337 354
7. B. Beutler A. Cerami The biology of cachectin/TNF—a primary mediator of the host response Annu Rev Immunol 7 1989 234 248
8. B. Beutler I.W. Milsark A. Cerami Cachectin/tumor necrosis factor: Production, distribution, and metabolic fate in vivo J Immunol 135 1985 3972 3977
9. M. Blick S.A. Sherwin M. Rosenblum Phase I study of recombinant tumor necrosis factor in cancer patients Cancer Res 47 1987 2986 2989
10. B. Bozkurt K. Shan Y. Seta Tumor necrosis factor-α and tumor necrosis factor receptors in human heart failure Heart Fail Rev 1 1996 211 219
11. C. Brakebusch Y. Nophar O. Kemper Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor EMBO J 11 1992 943 950
12. M.K. Chung T.S. Gulick R.E. Rotondo Mechanism of action of cytokine inhibition of β-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes: Impairment of signal transduction Circ Res 67 1990 753 763
13. A. Deswal Y. Seta C.M. Blosch A phase I trial of tumor necrosis factor receptor 9p75 fusion protein (TNFR:Fc) in patients with advanced heart failure [abstr] Circulation suppl 1997
14. B.J. Dezube A.B. Pardee B. Chapman Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS J Acquir Immune Defic Syndr Hum Retrovirol 6 1993 787 794
15. C.A. Dinarello Interleukin-1 Thompson A. The Cytokine Handbook 1991 Academic Press Boston 47 82
16. G.L. Engelmann D. Novick D. Wallach Two tumor necrosis factor-binding proteins purified from human urine J Biol Chem 265 1990 1531 1536
17. R. Ferrari T. Bachetti R. Confortini Tumor necrosis factor soluble receptors in patients with various degrees of congestive failure Circulation 92 1995 1479 1486
18. R. Gerli P. Rambotti F. Spinozzi Immunological studies of peripheral blood from patients with idiopathic dilated cardiomyopathy Am Heart J 112 1986 350 355
19. B.P. Giroir B. Beutler Effect of amrinone on tumor necrosis factor production in endotoxin shock Circ Shock 36 1992 200 207
20. B.P. Giroir J.H. Johnson T. Brown The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia J Clin Invest 90 1992 693 698
21. I. Guillen M. Blanes Gomez-Lechon M.-J. Cytokine signaling during myocardial infarction sequential appearance of IL-1β and IL-6 Am J Physiol 269 1995 R229 R235
22. F.M. Habib D.R. Springall G.J. Davies Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy Lancet 347 1996 1151 1155
23. S. Hegewisch H.J. Weh D.K. Hossfeld TNF-induced cardiomyopathy Lancet 2 1990 294 295
24. T. Hirano Interleukin-6 Thompson A. The Cytokine Handbook 1991 Academic Press Boston 169 190
25. S. Hwang T.J. Harris N.W. Wilson Immune function in patients with chronic stable congestive heart failure Am Heart J 125 1993 1651 1658
26. U. Ikeda F. Ohkawa Y. Seino Serum interleukin 6 levels become elevated in acute myocardial infarction J Mol Cell Cardiol 24 1992 579 584
27. J. Kalman B. Levine L. Mayer Prognostic importance of circulating neopterin levels in heart failure: Evidence for monocyte activation in patients with cardiac cachexia [abstr] Circulation 82 1990 III-315
28. S. Kapadia J.R. Lee G. Torre-Amione Tumor necrosis factor gene and protein expression in adult feline myocardium after endotoxin administration J Clin Invest 96 1995 1042 1052
29. S. Kapadia H. Oral J. Lee Hemodynamic regulation of tumor necrosis factor-α gene and protein expression in adult feline myocardium Circ Res 81 1997 187 195
30. S. Kapadia G. Torre-Amione T. Yokoyama Soluble tumor necrosis factor binding proteins modulate the negative inotropic effects of TNF-α in vitro Am J Physiol 37 1995 H517 H525
31. S.D. Katz R. Rao J.W. Berman Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure: Relation to nitric oxide-dependent vasodilation in the forearm circulation Circulation 90 1994 12 16
32. R. Klein B. Maisch K. Kochsiek Demonstration of organ specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases Clin Exp Immunol 58 1984 283 292
33. Lancaster S.M. Jr Laster L.R. Gooding Inhibition of target cell mitochondrial electron transfer by tumor necrosis factor FEBS Lett 248 1989 169 174
34. C.V. Leier P. Huss R.P. Lewis Drug-induced conditioning in congestive heart failure Circulation 65 1982 1382 1387
35. B. Levine J. Kalman L. Mayer Elevated circulating levels of tumor necrosis factor in severe chronic heart failure N Engl J Med 223 1990 236 241
36. C.J. Limas I.F. Goldenberg C. Limas Autoantibodies against β-adrenoceptors in human idiopathic dilated cardiomyopathy Circ Res 64 1989 97 103
37. G.A. MacGowan D.L. Mann R.L. Kormas Circulating interleukin-6 in severe heart failure Am J Cardiol 79 1997 1128 1131
38. D.L. Mann J.B. Young Basic mechanisms in congestive heart failure: Recognizing the role of proinflammatory cytokines Chest 105 1994 897 904
39. A. Matsumori T. Yamada H. Suzuki Increased circulating cytokines in patients with myocarditis and cardiomyopathy Br Heart J 72 1994 561 566
40. G.J. Mazzei P.L. Seckinger J.M. Dayer Purification and characterization of a 26-kDa competitive inhibitor of interleukin-1 Eur J Immunol 20 1990 683 689
41. J. McMurray I. Abdullah H.J. Dargie Increased concentrations of tumour necrosis factor in “cachectic” patients with severe chronic heart failure Br Heart J 66 1991 356 358
42. J. Medina L. Baud C.G. Escribano Tumor necrosis factor-induced contraction of cultured rat mesangial cells—interaction with angiotensin-II J Lab Clin Med 122 1993 164 172
43. R.V. Milani M.R. Mehra S. Endres The clinical relevance of circulating tumor necrosis factor-α in acute decompensated chronic heart failure without cachexia Chest 110 1996 992 997
44. A.B. Millar M. Singer A. Meager Tumor necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome Lancet 2 1989 712 713
45. Y. Miyao H. Yasue H. Ogawa Elevated plasma interleukin-6 levels in patients with acute myocardial infarction Am Heart J 126 1993 1299 1304
46. I.I.I. Mohleer L.C. Sorensen J.K. Ghali Role of cytokines in the mechanism of action of amlodipine: The PRAISE heart failure trial J Am Coll Cardiol 30 1997 35 41
47. M.A. Munger B. Johnson I.J. Amber Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 77 1996 723 727
48. C. Natanson P.W. Eichenholz R.L. Danner Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock J Exp Med 169 1989 823 832
49. Neumann F.-J. I. Ott M. Gawaz Cardiac release of cytokines and inflammatory responses in acute myocardial infarction Circulation 92 1995 748 755
50. K. Nishigaki S. Minatoguchi M. Seishima Plasma fas ligand, an inducer of apoptosis, and plasma soluble fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure J Am Coll Cardiol 29 1997 1214 1220
51. K. Ohlsson P. Bjork M. Bergenfeldt Interleukin-1 receptor antagonist reduces mortality from endotoxin shock Nature 348 1990 550 552
52. A. Oliff D. Defeo-Jones M. Boyer Tumors secreting human TNF/cachectin induce cachexia in mice Cell 50 1987 555 563
53. I. Olsson M. Lantz E. Nilsson Isolation and characterization of a tumor necrosis factor binding protein from urine Eur J Haematol 42 1989 270 275
54. M. Packer The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure J Am Coll Cardiol 20 1992 248 254
55. M. Packer How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the disease Am J Cardiol 71 1993 C3 C11
56. M. Packer C.M. O'Connor J.K. Ghali Effect of amlodipine on morbidity and mortality in severe chronic heart failure N Engl J Med 335 1996 1107 1114
57. F.D. Pagani L.S. Baker C. Hsi Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-α in conscious dogs J Clin Invest 90 1992 389 398
58. J.N. Palmer W.E. Hartogensis M. Patten Interleukin-1β induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture J Clin Invest 95 1995 2555 2564
59. J.E. Parrillo R.E. Cunnion S.E. Epstein A prospective randomized controlled trial of prednisone for dilated cardiomyopathy N Engl J Med 321 1989 1061 1068
60. 1-adrenergic induced gene expression in cultured cardiac myocytes J Biol Chem 271 1996 21134 21141
61. G. Pritchett H.J. Cohen K.M.K. Rao Tumor necrosis factor, natural killer activity and other measures of immune function and inflammation in elderly men with heart failure Gerontology 41 1995 45 56
62. M. Satoh M. Nakamura G. Tamura Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy J Am Coll Cardiol 29 1997 716 724
63. P.L. Seckinger J.W. Lowenthal K. Williamson A urine inhibitor of interleukin 1 activity that blocks ligand binding J Immunol 139 1987 1546 1549
64. H. Semb J. Peterson J. Tavernier Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo J Biol Chem 262 1987 8390 8394
65. Y. Seta K. Shan B. Bozkurt Basic mechanisms in heart failure: The cytokine hypothesis J Cardiac Failure 2 1996 243 249
66. R. Sindhwani J. Yuen H. Hirsch Reversal of low flow state attenuates immune activation in severe decompensated congestive heart failure [abstr] Circulation 88 1993 I-255
67. S.H. Socher A. Friedman D. Martinez Recombinant human tumor necrosis factor induces reductions in food intake and body weight in mice J Exp Med 167 1988 1957 1962
68. B.M. Spiegelman G.S. Hotamisligil Through thick and thin: Wasting, obesity, and TNFα Cell 73 1993 625 627
69. J. Stadler B.G. Bentz B.G. Harbrecht Tumor necrosis factor alpha inhibits hepatocyte mitochondrial respiration Ann Surg 216 1992 539 546
70. A.F. Suffredini R.E. Fromm M.M. Parker The cardiovascular response of normal humans to the administration of endotoxin N Engl J Med 321 1989 280 287
71. A. Sugawara K. Nakao N. Morii α-Human atrial natriuretic polypeptide is released from the heart and circulates in the body Biochem Biophys Res Commun 129 1985 439 446
72. A. Sugawara K. Nakao N. Morii Significance of α-human atrial natriuretic polypeptide as a hormone in man Hypertension 8 1986 I-151 I-162
73. H. Tashiro H. Shimokawa K. Yamamoto Monocyte-related cytokines in acute myocardial infarction Am Heart J 130 1995 446 452
74. M. Testa M. Yeh P. Lee Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension J Am Coll Cardiol 28 1996 964 971
75. C.M. Thaik A. Calderone N. Takahashi Interleukin-1β modulates the growth and phenotype of neonatal rat cardiac myocytes J Clin Invest 96 1995 1093 1099
76. G. Torre-Amione S. Kapadia C. Benedict Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the Studies of Left Ventricular Dysfunction (SOLVD) J Am Coll Cardiol 27 1996 1201 1206
77. G. Torre-Amione S. Kapadia J. Lee Expression and functional significance of tumor necrosis factor receptors in human myocardium Circulation 92 1995 1487 1493
78. G. Torre-Amione S. Kapadia J. Lee Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart Circulation 93 1996 704 711
79. T. Tsutamoto A. Wada Y. Maeda Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure J Am Coll Cardiol 23 1994 1427 1433
80. D.V. Unverferth R.D. Magorien R.P. Lewis Long-term benefit of dobutamine in patients with congestive cardiomyopathy Am Heart J 100 1980 622 630
81. C.J. Wiedermann H. Beimpold M. Herold Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha J Am Coll Cardiol 22 1993 1897 1901
82. K. Yoshida T. Taga M. Saito Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders Proc Natl Acad Sci U S A 93 1996 407 411
83. K. Youker C.W. Smith D.C. Anderson Neutrophil adherence to isolated adult cardiac myocytes: Induction by cardiac lymph collected during ischemia and reperfusion J Clin Invest 89 1992 602 609
84. P. Zabel U. Greinert P. Entzian Effects of pentoxifylline on circulating cytokines (TNF and IL-6) in severe pulmonary tuberculosis Fiers W. Buurman W.A. Tumor Necrosis Factor: Molecular and Cellular Biology and Clinical Relevance 1993 S Karger Basel 178 181
85. P. Zabel F.U. Schade M. Schlaak Inhibition of endogenous TNF formation by pentoxifylline Immunbiology 187 1993 447 463